Cummings F, Smith PJ, Fumery M, Rahmany S, et al. Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease: An individual participant data meta-analysis. J Clin Gastroenterol 2025 Aug 6. doi: 10.1097/MCG.0000000000002228.
PMID: 40824626